Literature DB >> 29886030

Optimization of a high-cell-density polyethylenimine transfection method for rapid protein production in CHO-EBNA1 cells.

Matthew Stuible1, Alina Burlacu1, Sylvie Perret1, Denis Brochu1, Béatrice Paul-Roc1, Jason Baardsnes1, Martin Loignon1, Eric Grazzini1, Yves Durocher2.   

Abstract

For pre-clinical evaluation of biotherapeutic candidates, protein production by transient gene expression (TGE) in Chinese Hamster Ovary (CHO) cells offers important advantages, including the capability of rapidly and cost-effectively generating recombinant proteins that are highly similar to those produced in stable CHO clones. We have established a novel CHO clone (CHO-3E7) expressing a form of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) with improved TGE productivity relative to parental CHO cells. Taking advantage of a new transfection-compatible media formulation that permits prolonged, high-density culture, we optimized transfection parameters (cell density, plasmid vector and polyethylenimine concentrations) and post-transfection culture conditions to establish a new, high-performing process for rapid protein production. The growth media is chemically defined, and a single hydrolysate feed is added post-transfection, followed by periodic glucose supplementation. This method gave significantly higher yields than our standard low-cell density, F17-based CHO-3E7 TGE method, averaging several hundred mg/l for a panel of recombinant proteins and antibodies. Purified antibodies produced using the two methods had distinct glycosylation profiles but showed identical target binding kinetics by SPR. Key advantages of this new protein production platform include the cost-effectiveness of the transfection reagent, the commercial availability of the culture media and the ability to perform high-cell-density transfection without media change. Crown
Copyright © 2018. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CHO cells; Monoclonal antibodies; Recombinant proteins; Transient gene expression

Mesh:

Substances:

Year:  2018        PMID: 29886030     DOI: 10.1016/j.jbiotec.2018.06.307

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  12 in total

1.  An anti-apoptotic HEK293 cell line provides a robust and high titer platform for transient protein expression in bioreactors.

Authors:  Tia A Arena; Bernice Chou; Peter D Harms; Athena W Wong
Journal:  MAbs       Date:  2019-04-24       Impact factor: 5.857

Review 2.  Progress of cationic gene delivery reagents for non-viral vector.

Authors:  Kai Ma; Chun-Liu Mi; Xiang-Xiang Cao; Tian-Yun Wang
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 4.813

3.  Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters.

Authors:  Felicity C Stark; Bassel Akache; Lise Deschatelets; Anh Tran; Matthew Stuible; Yves Durocher; Michael J McCluskie; Gerard Agbayani; Renu Dudani; Blair A Harrison; Tyler M Renner; Shawn R Makinen; Jegarubee Bavananthasivam; Diana Duque; Martin Gagne; Joseph Zimmermann; C David Zarley; Terrence R Cochrane; Martin Handfield
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

4.  Redesigning an antibody H3 loop by virtual screening of a small library of human germline-derived sequences.

Authors:  Christopher R Corbeil; Mahder Seifu Manenda; Traian Sulea; Jason Baardsnes; Marie-Ève Picard; Hervé Hogues; Francis Gaudreault; Christophe Deprez; Rong Shi; Enrico O Purisima
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.996

5.  Pulsed Electric Fields Alter Expression of NF-κB Promoter-Controlled Gene.

Authors:  Justina Kavaliauskaitė; Auksė Kazlauskaitė; Juozas Rimantas Lazutka; Gatis Mozolevskis; Arūnas Stirkė
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

6.  Identification of RNase-sensitive LINE-1 Ribonucleoprotein Interactions by Differential Affinity Immobilization.

Authors:  Hua Jiang; Martin S Taylor; Kelly R Molloy; Ilya Altukhov; John LaCava
Journal:  Bio Protoc       Date:  2019-04-05

7.  A simple protein-based surrogate neutralization assay for SARS-CoV-2.

Authors:  Kento T Abe; Zhijie Li; Reuben Samson; Payman Samavarchi-Tehrani; Emelissa J Valcourt; Heidi Wood; Patrick Budylowski; Alan P Dupuis; Roxie C Girardin; Bhavisha Rathod; Jenny H Wang; Miriam Barrios-Rodiles; Karen Colwill; Allison J McGeer; Samira Mubareka; Jennifer L Gommerman; Yves Durocher; Mario Ostrowski; Kathleen A McDonough; Michael A Drebot; Steven J Drews; James M Rini; Anne-Claude Gingras
Journal:  JCI Insight       Date:  2020-10-02

8.  Characterization and mitigation of gene expression burden in mammalian cells.

Authors:  Timothy Frei; Federica Cella; Fabiana Tedeschi; Joaquín Gutiérrez; Guy-Bart Stan; Mustafa Khammash; Velia Siciliano
Journal:  Nat Commun       Date:  2020-09-15       Impact factor: 14.919

9.  Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia.

Authors:  Zhengli Bai; Menglong Xu; Ying Mei; Tuo Hu; Panpan Zhang; Manman Chen; Wenxiu Lv; Chenchen Lu; Shuhua Tan
Journal:  Biomedicines       Date:  2021-11-27

10.  Suitability of transiently expressed antibodies for clinical studies: product quality consistency at different production scales.

Authors:  Sara Rodriguez-Conde; Sophie Inman; Viv Lindo; Leanne Amery; Alison Tang; Uche Okorji-Obike; Wenjuan Du; Berend-Jan Bosch; Paul J Wichgers Schreur; Jeroen Kortekaas; Isabel Sola; Luis Enjuanes; Laura Kerry; Katharina Mahal; Martyn Hulley; Olalekan Daramola
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.